Raffles PharmaTech is a CDMO formed in 2011 that supports innovative pharmaceutical clients globally with custom small molecule contract development and manufacturing of drug substances.
Services in route discovery, process development, optimization, scale-up, and cGMP manufacture of advanced intermediates, KSMs, RSMs and API for all stages of development from discovery, clinical, through to commercial quantities.
With ~400 employees, Raffles operates two sites in Guangdong, China, an R&D site in Pingshan made up of 6,000 m² of synthesis and analytical development lab space and a 7-acre cGMP manufacturing site located in Dayawan Bay which was opened in 2021 with modular trains, ranging from 50L-5,000 L reactor sizes and capabilities in, cryogenics/high-temperature, hydrogenation equipment including Hastelloy, and two kilo scale facilities cGMP and non-cGMP. We have containment facilities to operate up to OEB3/4 control.
Our expertise covers a range of molecule types and processing complexities at scale.